139 related articles for article (PubMed ID: 35672528)
1. Network pharmacological evaluation of strigolactones efficacy as potential inhibitors against therapeutic targets of hepatocellular carcinoma.
Amod A; Pahal S; Choudhary P; Gupta A; Singh S
Biotechnol Lett; 2022 Jul; 44(7):879-900. PubMed ID: 35672528
[TBL] [Abstract][Full Text] [Related]
2. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
3. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
[TBL] [Abstract][Full Text] [Related]
4. Acteoside (Verbascoside): A Prospective Therapeutic Alternative against Hepatocellular Carcinoma by Inhibiting the Expression of AXL, FGFR, BRAF, TIE2 and RAF1 Targets.
Kityania S; Nath R; Nath D; Patra JK; Talukdar AD
Comb Chem High Throughput Screen; 2023; 26(10):1907-1919. PubMed ID: 36321230
[TBL] [Abstract][Full Text] [Related]
5. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
[TBL] [Abstract][Full Text] [Related]
6. Multilevel data integration and molecular docking approach to systematically elucidate the underlying pharmacological mechanisms of Er-Zhi-Wan against hepatocellular carcinoma.
Zheng S; Pan B
Aging (Albany NY); 2022 Nov; 14(21):8783-8804. PubMed ID: 36347033
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21
Zhou H; Cai Y; Liu D; Li M; Sha Y; Zhang W; Wang K; Gong J; Tang N; Huang A; Xia J
Cell Prolif; 2018 Jun; 51(3):e12447. PubMed ID: 29484736
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumorigenic Efficacy of Tangeretin in Liver Cancer - An In Silico Approach.
P S; K L
Curr Comput Aided Drug Des; 2021; 17(3):337-343. PubMed ID: 32072904
[TBL] [Abstract][Full Text] [Related]
9. Effect of gigantol on the proliferation of hepatocellular carcinoma cells tested by a network-based pharmacological approach and experiments.
Li S; Li H; Yin D; Xue X; Chen X; Li X; Li J; Yi Y
Front Biosci (Landmark Ed); 2022 Jan; 27(1):25. PubMed ID: 35090330
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of Puerariae Lobatae Radix in treatment of hepatocellular carcinoma based on network pharmacology].
Min Z; Yuan Z; Ye C; Nan XU; Wei-Bing LI; Cheng-Yu WU; Yan C
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4089-4098. PubMed ID: 33164393
[TBL] [Abstract][Full Text] [Related]
11. Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor.
Nair G; Hema Sree GNS; Saraswathy GR; Marise VLP; Krishna Murthy TP
Med Oncol; 2021 Oct; 38(12):145. PubMed ID: 34687371
[TBL] [Abstract][Full Text] [Related]
12. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
[TBL] [Abstract][Full Text] [Related]
13. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
Li M; Shang H; Wang T; Yang SQ; Li L
World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
[TBL] [Abstract][Full Text] [Related]
14. Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19.
Huang Y; Yuan Y; Chen S; Xu D; Xiao L; Wang X; Qin W; Liu B
Front Immunol; 2022; 13():985781. PubMed ID: 36275701
[TBL] [Abstract][Full Text] [Related]
15. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
[TBL] [Abstract][Full Text] [Related]
16. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
[TBL] [Abstract][Full Text] [Related]
17. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
[TBL] [Abstract][Full Text] [Related]
18. In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug.
Shi XN; Li H; Yao H; Liu X; Li L; Leung KS; Kung HF; Lu D; Wong MH; Lin MC
PLoS One; 2015; 10(7):e0132072. PubMed ID: 26147897
[TBL] [Abstract][Full Text] [Related]
19.
Keshari AK; Singh AK; Raj V; Rai A; Trivedi P; Ghosh B; Kumar U; Rawat A; Kumar D; Saha S
Drug Des Devel Ther; 2017; 11():1623-1642. PubMed ID: 28615927
[TBL] [Abstract][Full Text] [Related]
20. 7-Deoxynarciclasine shows promising antitumor efficacy by targeting Akt against hepatocellular carcinoma.
Yin S; Qiu Y; Jin C; Wang R; Wu S; Liu H; Koo S; Han L; Zhang Y; Gao X; Pang X; Wang T; Yu H
Int J Cancer; 2019 Dec; 145(12):3334-3346. PubMed ID: 31081930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
